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Background: The number of total knee replacements has substantially increased worldwide over the past ten years.
Several studies have indicated a correlation between high hospital procedure volume and decreased morbidity and
mortality following total knee arthroplasty. The purpose of the present study was to evaluate whether there is a correlation
between procedure volume and the risk of revision following total knee arthroplasty with use of hospital volume data from
the Norwegian Arthroplasty Register.
Methods: Thirty-seven thousand, three hundred and eighty-one total knee arthroplasties that were reported to the
Norwegian Arthroplasty Register from 1994 to 2010 were used to examine the annual procedure volume per hospital.
Hospital volume was divided into five categories according to the number of procedures performed annually: one to twenty-
four (low volume), twenty-five to forty-nine (medium volume), fifty to ninety-nine (medium volume), 100 to 149 (high
volume), and ‡150 (high volume). Cox regression (adjusted for age, sex, and diagnosis) was used to estimate the proportion
of procedures without revision and the risk ratio (RR) of revision. Analyses were also performed for two commonly used
prosthesis brands combined.
Results: The rate of prosthetic survival at ten years was 92.5% (95% confidence interval, 91.5 to 93.4) for hospitals with
an annual volume of one to twenty-four procedures and 95.5% (95% confidence interval, 94.1 to 97.0) for hospitals with an
annual volume of ‡150 procedures. We found a significantly lower risk of revision for hospitals with an annual volume of
100 to 149 procedures (relative risk = 0.73 [95% confidence interval, 0.56 to 0.96], p = 0.03) and ‡150 procedures
(relative risk = 0.73 [95% confidence interval, 0.54 to 1.00], p = 0.05) compared with hospitals with an annual volume of
one to twenty-four procedures. Similar results were found when we analyzed two commonly used prosthesis brands.
Conclusions: In the present study, there was a significantly higher rate of revision knee arthroplasties at low-volume
hospitals as compared with high-volume hospitals.
Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
T
otal knee arthroplasty is now a common and increas-
ingly used surgical procedure that, in some countries,
has bypassed total hip arthroplasty in terms of the
number of procedures performed1. It is an established proce-
dure with a high rate of patient satisfaction for the treatment of
knee osteoarthritis2. There are multiple factors that may affect
the outcome of total knee arthroplasty3-5. Patient characteristics
and surgical indications, surgical technique, the quality of the
implant and the bone cement, and implant-specific education
are all factors that affect surgical quality. Hospital and surgeon
volume are also considered to be important factors6,7, but not
all studies have demonstrated an association between surgeon
volume and implant survival after total knee arthroplasty8.
There have been reports of higher risks of perioperative and
postoperative complications and higher rates of mortality fol-
lowing procedures performed at low-volume hospitals9-11.
Some studies have shown a correlation between higher pro-
cedure volume and shorter length of hospital stay after total
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knee arthroplasty12,13. Others have shown that there is coher-
ence between low volume and inferior functional outcome
after total knee arthroplasty14. A higher short-term risk of
complications after total knee arthroplasty has been associated
with lower hospital and surgeon volumes, but very few studies
have proven a relationship between procedure volume and im-
plant survival. A study from the United States involving Medi-
care data suggested that procedures performed at low-volume
hospitals are associated with a greater risk of revision at the time
of intermediate-term follow-up (five and eight years)8. To our
knowledge, there have been no studies involving national im-
plant registry data that have investigated a possible correlation
between hospital volumes and the rate of revision following total
knee arthroplasty. Because of the large number of hospitals and
procedures involved15, the Norwegian Arthroplasty Register
provides valuable and dependable measures that can used to
analyze different volume-groups in order to evaluate the asso-
ciation between volume and the rate of revision.
The purpose of the present study was to evaluate whether
there is a correlation between procedure volume and the risk of
revision following total knee arthroplasty with use of hospital
volume data from the Norwegian Arthroplasty Register.
Materials and Methods
The Norwegian Arthroplasty Register was established in 1987 and initiallyincluded only hip arthroplasties. In 1994, the register started to include
knee arthroplasties. The Norwegian Arthroplasty Register includes 99% of





The Norwegian Arthroplasty Register contains data on 37,381 primary total
knee arthroplasties that were performed during the time period from 1994 to
2010. Thirty-three thousand, three hundred and seventeen (89%) of these total
knee arthroplasties were performed without a patellar component, and, among
these, 84% were performed with cement. To examine the annual surgery vol-
ume per hospital, we analyzed registry data for total knee arthroplasty proce-
dures that were performed with cement and without a patellar component from
1994 to 2010. We selected this implant group because cemented implants
without a patellar component are preferred at the majority of hospitals in
Norway. We excluded implant brands that are rarely used, such as posterior
stabilized designs (1180 implants) and hinged prostheses (sixty-five implants).
After these exclusions, a total of 26,698 total knee arthroplasty procedures were
analyzed (Fig. 1).
Hospital volume was categorized into five volume-groups (one to
twenty-four, twenty-five to forty-nine, fifty to ninety-nine, 100 to 149, and ‡150).
These cut-points were based on the mean annual numbers of total hip arthro-
plasties for the years 1994 to 2010 as reported in other similar studies
9,16,17
.
Because of the small number of revision arthroplasties, adjustment for
prosthesis brand could not be done in the Cox model. We therefore performed
a subanalysis on the AGC (Biomet, Warsaw, Indiana) and LCS (DePuy, Warsaw,
Indiana) implants combined as these implants are commonly used and are well
represented in all of the volume groups (with 1630 such implants in the one to
twenty-four-procedure group, 2239 in the twenty-five to forty-nine-procedure
group, 2250 in the fifty to ninety-nine-procedure group, 955 in the 100 to 149-
procedure group, and 172 in the ‡150-procedure group).
Statistical Analysis
Descriptive analyses were used to assess patient characteristics for the different
hospital and surgeon volume categories. Survival analyses were performed with
revision of the prosthesis for any reason as the end point. Information on deaths
and emigrations was retrieved from the National Population Register until
December 31, 2010. The survival times of unrevised implants were censored at
the date of death or emigration or at the last date of observation (December 31,
2010). Kaplan-Meier estimated survival curves were constructed for hospital
volume categories, and the survival percentages at ten years are reported. To
evaluate the effect of volume on prosthetic survival, we used the Cox regression
model to calculate risk ratios (RR). These values are presented with 95%
confidence intervals and p values relative to the lowest-volume group.
The Cox regression results regarding hospital volume were adjusted for
age, sex, and diagnosis. Cox regression analyses with volume group as a strat-
ification factor were used to construct adjusted survival curves. As many
prosthesis brands had been used in small numbers and were associated with
few revisions, adjustment for brand was not feasible in the Cox analyses. We
therefore performed a subanalysis with the AGC and LCS implants combined.
Source of Funding
There was no external funding source.
Fig. 1
Twenty-six thousand, six hundred and ninety-eight total knee arthroplasties
(TKA) were selected for inclusion in this study. Knees that were treated with
unicompartmental knee arthroplasty, uncemented total knee arthroplasty,
total knee arthroplasty with a patellar component, cement without anti-
biotics, and uncommondesigns and brands were excluded.NAR = National
Arthroplasty Register, PS = posterior stabilized.
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Results
The registration form in the Norwegian Arthroplasty Reg-ister includes information on patient characteristics, diag-
nosis, previous surgery on the knee, implant brand and type,
fixation method, and other relevant data. Revision was defined as
partial or complete removal or exchange of one or more implant
components and was linked to the primary surgical procedure by
the unique national identification number of the patient.
The patient and procedure characteristics according to
hospital volume are shown in Table I.
Hospital Volume
The hospitals with an annual volume of one to twenty-four
procedures accounted for 4685 implants (17.5%), those with
an annual volume of twenty-five to forty-nine procedures
accounted for 7497 implants (28.1%), those with an annual
volume of fifty to ninety-nine procedures accounted for 10,551
implants (39.5%), those with an annual volume of 100 to 149
procedures accounted for 2131 implants (8.0%), and those
with an annual volume of ‡150 procedures accounted for 1834
implants (6.9%). The higher-volume group did not have the
highest number of patients because higher-volume hospitals
were uncommon during the first years of registration (Fig. 2).
The majority of hospitals had a gradual increase in annual
hospital volume over time, but a few hospitals continued to be
low-volume units and some stopped performing this procedure.
The percentage of hospitals performing fewer than
twenty-five total knee arthroplasties per year decreased, and the
percentage of hospitals performing ‡100 total knee arthro-
plasties per year increased. In 1995, 88% of the hospitals per-
formed fewer than fifty procedures annually. In 2010, 84% of the
hospitals performed at least fifty procedures annually (Fig. 2).
The rate of prosthetic survival at ten years was 92.5%
(95% confidence interval [CI], 91.5 to 93.4) for hospitals with
an annual volume of one to twenty-four procedures and 95.5%
(95% CI, 94.1 to 97.0) for hospitals with an annual volume of
‡150 procedures (Table II).
The risk of revision was assessed in comparison with the
results for the low-volume hospitals (one to twenty-four pro-
cedures annually). Compared with knees that had been treated
at hospitals with an annual volume of one to twenty-four
procedures, those that had been treated at hospitals with an
annual volume of twenty-five to forty-nine and fifty to ninety-
nine procedures had lower risks of revision, but the differences









No. of procedures 4685 7497 10,551 2131 1834
Male sex (%) 29 31 33 37 32
Age† (yr) 72 (20 to 93) 72 (22 to 92) 71 (26 to 96) 71 (22 to 92) 70 (31 to 91)
Osteoarthritis (%) 81 85 88 90 87
Common implants‡ (%)
Profix (7002 implants) 23 30 33 6 0
LCS Complete (5501 implants) 8 8 26 22 80
AGC (3759 implants) 20 15 11 15 8
LCS (3511 implants) 15 14 10 30 2
Genesis I (2049 implants) 12 15 3 0 0
Duracon (1945 implants) 6 7 7 19 0
Cement with antibiotics (%) 96 98 99 100 100
*Patient and procedure characteristics for 26,698 total knee arthroplasties performed with cement and without patellar resurfacing from 1994 to
2010 in Norway for five different hospital volume categories. †The values are given as the median, with the range in parentheses. ‡The values are
expressed as the percentage of implants in each volume group. The most commonly used implants are shown. (A total of twenty-three different
implant brands were registered in the Norwegian Arthroplasty Register. The six brands listed above constituted 89% of the total number of
implants.)
Fig. 2
Bar graph showing the change in hospital volumes over time, with the three
columns indicating the years of 1995, 2000, and 2010.
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were not significant (RR = 0.94 [95% CI, 0.80 to 1.09], p = 0.40
and RR = 0.93 [95% CI, 0.80 to 1.09], p = 0.35, respectively).
There was a significant difference between the hospitals with an
annual volume of 100 to 149 procedures and the low-volume
units (RR = 0.73 [95% CI, 0.56 to 0.96], p = 0.03). The hos-
pitals with an annual volume of ‡150 procedures had the
lowest risk of revision compared with the other groups (RR =
0.73 [95% CI, 0.54 to 1.00], p = 0.05) (Table II). These num-
bers indicate an influence of hospital volume on the risk of
revision in favor of the high-volume hospitals (Fig. 3).
TABLE II Cox Regression Analysis
Annual Hospital Volume






at 10 Years* (%) Adjusted RR*† P Value
<25 procedures 4685 280 92.5 (91.5 to 93.4) 1
25 to 49 procedures 7497 373 93.1 (92.3 to 93.9) 0.94 (0.80 to 1.09) 0.40
50 to 99 procedures 10551 405 93.0 (92.0 to 94.0) 0.93 (0.80 to 1.08) 0.35
100 to 149 procedures 2131 64 94.7 (93.0 to 96.3) 0.73 (0.56 to 0.96) 0.03
‡150 procedures 1834 47 95.5 (94.1 to 97.0)‡ 0.73 (0.54 to 1.00) 0.05
*The 95% CI is given in parentheses. †Estimated risk ratio with adjustment for age, sex, and diagnosis. ‡Estimated survival at five years (last
revision).
Fig. 3 Fig. 4
Fig. 3 Kaplan-Meier survival curves for total knee arthroplasties performed with cement and without patellar resurfacing in Norway from 1994 to 2010,
with revision for any reason as the end point. The results of Cox regression analysis were adjusted for age, sex, and diagnosis. The results are shown for
the five different hospital volume groups described in the text. Fig. 4 Kaplan-Meier survival curves for total knee arthroplasties performed with cemented
AGC and LCS implants without patellar resurfacing from 1994 to 2010, with revision for any reason as the end point. The results of Cox regression analysis
were adjusted for age, sex, and diagnosis. The results are shown for the five different hospital volume groups described in the text.
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In the subanalysis of AGC and LCS implants, we ob-
served similar and corresponding results. Compared with
knees that had been treated at hospitals with an annual volume
of one to twenty-four procedures, those that had been treated
at hospitals with an annual volume of twenty-five to forty-nine
and fifty to ninety-nine procedures had lower risks of revision,
but the differences were not significant (RR = 1.10 [p = 0.49]
and RR = 0.82 [p = 0.17], respectively). A significant difference
was found between the hospitals with an annual volume of 100
to 149 procedures and the low-volume hospitals (RR = 0.56;
p = 0.007). The hospitals with an annual volume of ‡150 pro-
cedures had a low number of procedures and revisions com-
pared with the other volume groups for these specific implant
brands and did not have significant improvements regarding the
risk of revision (RR = 0.81; p = 0.68) (Fig. 4).
Discussion
This register-based study indicates that there was significantlybetter prosthetic survival following procedures performed at
higher-volume hospitals as compared with low-volume hospitals
during 1994 to 2010. However, these results might be influenced
by several other factors18,19.
To study the influence of annual hospital volume on
prosthetic survival, we used registry data from the Norwe-
gian Arthroplasty Register to estimate the proportions of
procedures without revision and relative differences in the
risk of revision. Although the registry data do not include
functional outcome after this procedure, the revision rate is
an important measure of the clinical outcome of total knee
arthroplasty.
Comparison with Relevant Studies
The implants that were used in the later years may have been of
better quality, and the surgical technique has improved, as has
been shown for total hip arthroplasties with cement20. Styron
et al. demonstrated that the annual volume of total knee ar-
throplasty procedures performed by the surgeon and hospital
had a greater impact on the length of hospital stay than patient-
related characteristics did13. The gradual improvement of the
survival curve following total knee arthroplasty might be
multifactorial, but the impact of volume probably is a crucial
contributor. The benefits of high volume probably include not
only improved surgical technique but also a better under-
standing of the importance of patient selection and the indi-
cations for surgery.
A higher short-term risk of complications such as wound
infection after total knee arthroplasty has been associated
with lower hospital and surgeon volume21. There also have
been reports of higher risks of perioperative and postoper-
ative complications and adverse outcomes (including pneu-
monia, acute myocardial infarction, pulmonary embolus,
and deep infection) and higher rates of mortality in low-volume
hospitals9-11. Other reports have indicated that there is coherence
between low volume and inferior functional outcome following
total knee arthroplasty14. Widespread differences have been
reported in hospital volume definitions, with between two
and five hospital volume categories being used. The volume
groups also differ in size. These discrepancies limit the conclu-
siveness of results16.
Strengths and Limitations
Arthroplasty registers offer the ability to analyze outcome and
to provide early warnings of failing implants and methods22.
Except for revision, the Norwegian Arthroplasty Register does
not include any clinical outcome data, which is considered a
disadvantage. However, the Norwegian Arthroplasty Register
has registered knee arthroplasties since 1994 and provides re-
liable measures of the change in volume over time. We there-
fore consider the results for hospital volume to be accurate.
However, we are aware of other relevant factors contributing to
the improving results in total knee arthroplasty, such as im-
provements in surgical and cementing techniques, implants,
and implant-specific education.
We did not adjust for prosthesis brand when analyzing
hospital volume, which might be considered to be a weakness.
However, we compensated for this by performing a separate
analysis of two commonly used brands that were well represented
in all volume categories and achieved corresponding results. A
recent study from the Norwegian Arthroplasty Register evaluated
the different knee prosthesis brands and demonstrated that
the implant most commonly used in the high-volume centers
(Table I) had an average result when compared with the other
implant brands and was not among the implants with the lowest
risk of revision23.
Explanations and Mechanisms
Standardization of procedure and care is important4 and is well
established in our country as nearly all procedures involve the
use of cemented implants, antibiotics in the cement, periop-
erative antibiotic prophylaxis, antithrombosis prophylaxis, and
some kind of rehabilitation after surgery. All resident ortho-
paedic surgeons in Norway are required to complete a practical
and theoretical prosthesis course, and a textbook has been
written for this course24. Patient selection and indications also
play an important role in the outcome of total knee arthro-
plasty. Survival curves from the different national arthroplasty
registers show a gradual improvement over time from 1994 to
2010 for the results of total knee arthroplasty25,26. Some of this
effect might be volume-related.
In conclusion, in the present study, we found a signifi-
cantly higher rate of revision following knee arthroplasties
performed in low-volume hospitals as compared with high-
volume hospitals. n
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